Copenhagen - Delayed Quote • DKK H. Lundbeck A/S (HLUN-B.CO) Follow Compare 40.60 -0.76 (-1.84%) At close: January 10 at 4:59:52 PM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Lundbeck to acquire Longboard Pharmaceuticals in $2.6B deal Danish pharmaceutical company Lundbeck will buy Longboard Pharmaceuticals (LBPH) in a deal valued at $2.6 billion, with the former hoping to build off of its pipeline of epilepsy drug treatment. Market Domination hosts Julie Hyman and Josh Lipton take a closer look at the details of the deal. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Luke Carberry Mogan. Performance Overview Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index Return HLUN-B.CO OMX Copenhagen 25 Index YTD -1.74% +0.08% 1-Year +20.21% -4.27% 3-Year +11.54% -4.80%